Literature DB >> 16400321

Peritumoral lymphatic invasion is associated with regional lymph node metastases in prostate adenocarcinoma.

Andres A Roma1, Cristina Magi-Galluzzi, Melinda A Kral, Tao T Jin, Eric A Klein, Ming Zhou.   

Abstract

Lymphangiogenesis, detected by antibodies specific for lymphatic endothelial cells, has been associated with regional lymph node metastases and poor prognosis in carcinomas of head and neck, breast and uterine cervix, but remains largely uninvestigated in prostate adenocarcinoma. We evaluated the lymphatic vessel density and lymphatic vessel invasion by prostate cancer cells in the intratumoral, peritumoral and normal prostate tissue compartments in cancer-bearing prostate glands and correlated them with lymph node metastases, Gleason score and other pathological parameters. Lymphatic vessels were detected by immunohistochemical stain using an antibody specific for the lymphatic endothelial cells (clone D2-40) on 33 radical prostatectomies. In all, 26 patients had lymph node dissection, and 14 of them had lymph node metastasis. The lymphatic vessel density and lymphatic vessel invasion were then recorded for each of the three compartments microscopically. Lymphatic vessel density in the intratumoral, peritumoral and normal prostate compartments was 0.91+/-0.80, 1.54+/-0.68 and 1.58+/-0.96/mm2, respectively. The intratumoral lymphatic vessel density was significantly lower than that of the peritumoral and normal prostate compartments, and the latter two were not significantly different. The lymphatic vessel density of the three compartments was not significantly different between cases with and without lymph node metastasis. The peritumoral lymphatic vessel density correlated inversely with the Gleason score. Lymphatic vessel invasion was present in significantly higher percentage of cases with lymph node metastasis (9/14, 62.3%), as compared to those without lymph node metastasis (1/12, 8.3%, P<0.01). The peritumoral lymphatic vessel invasion had a better correlation with the presence of lymph node metastases than intratumoral lymphatic vessel invasion. There is no evidence of lymphangiogenesis in prostate adenocarcinoma. Peritumoral lymphatic vessel invasion correlates with regional lymph node metastases, suggesting that the peritumoral lymphatic vessels are functionally important and identification of lymphatic vessel invasion in this compartment implies a high probability of regional lymph node metastases.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16400321     DOI: 10.1038/modpathol.3800546

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  31 in total

Review 1.  Semaphorin signaling in angiogenesis, lymphangiogenesis and cancer.

Authors:  Atsuko Sakurai; Colleen L Doçi; Colleen Doci; J Silvio Gutkind
Journal:  Cell Res       Date:  2011-12-13       Impact factor: 25.617

2.  Expression of podoplanin in the invasion front of oral squamous cell carcinoma is not prognostic for survival.

Authors:  Juan Carlos de Vicente; Tania Rodríguez Santamarta; Juan Pablo Rodrigo; Juana María García-Pedrero; Eva Allonca; Verónica Blanco-Lorenzo
Journal:  Virchows Arch       Date:  2015-03-01       Impact factor: 4.064

3.  Cryptotanshinone inhibits lymphatic endothelial cell tube formation by suppressing VEGFR-3/ERK and small GTPase pathways.

Authors:  Yan Luo; Wenxing Chen; Hongyu Zhou; Lei Liu; Tao Shen; J Steven Alexander; Shizhong Zheng; Yin Lu; Shile Huang
Journal:  Cancer Prev Res (Phila)       Date:  2011-08-31

Review 4.  Prognostic significance of lymphovascular invasion in radical prostatectomy specimens.

Authors:  David S Yee; Shahrokh F Shariat; William T Lowrance; Alexandra C Maschino; Caroline J Savage; Angel M Cronin; Peter T Scardino; James A Eastham
Journal:  BJU Int       Date:  2010-11-02       Impact factor: 5.588

5.  Integrin alpha4beta1 signaling is required for lymphangiogenesis and tumor metastasis.

Authors:  Barbara Garmy-Susini; Christie J Avraamides; Michael C Schmid; Philippe Foubert; Lesley G Ellies; Leo Barnes; Chloe Feral; Thalia Papayannopoulou; Andrew Lowy; Sarah L Blair; David Cheresh; Mark Ginsberg; Judith A Varner
Journal:  Cancer Res       Date:  2010-04-13       Impact factor: 12.701

6.  Periacinar retraction clefting and d2-40 expression in prostatic adenocarcinoma.

Authors:  Monika Ulamec; Tihana Džombeta; Hrvoje Cupić; Tanja Leniček; Davor Tomas; Božo Krušlin
Journal:  Pathol Oncol Res       Date:  2011-09-13       Impact factor: 3.201

7.  Inducible Nitric Oxide Synthase and CD11b+Gr1+ Cells Impair Lymphatic Contraction of Tumor-Draining Lymphatic Vessels.

Authors:  Shan Liao; Echoe M Bouta; Linda M Morris; Dennis Jones; Rakesh K Jain; Timothy P Padera
Journal:  Lymphat Res Biol       Date:  2018-10-24       Impact factor: 2.589

8.  Suppression of prostate cancer nodal and systemic metastasis by blockade of the lymphangiogenic axis.

Authors:  Jeremy B Burton; Saul J Priceman; James L Sung; Ebba Brakenhielm; Dong Sung An; Bronislaw Pytowski; Kari Alitalo; Lily Wu
Journal:  Cancer Res       Date:  2008-10-01       Impact factor: 12.701

Review 9.  Integrins in angiogenesis and lymphangiogenesis.

Authors:  Christie J Avraamides; Barbara Garmy-Susini; Judith A Varner
Journal:  Nat Rev Cancer       Date:  2008-05-22       Impact factor: 60.716

10.  Association of serum vascular endothelial growth factor-C and lymphatic vessel density with lymph node metastasis and prognosis of patients with gastric cancer.

Authors:  Tian-Bao Wang; Mei-Hai Deng; Wan-Shou Qiu; Wen-Guang Dong
Journal:  World J Gastroenterol       Date:  2007-03-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.